Clinical Trials Logo

Clinical Trial Summary

The aim of this trial was to investigate the efficacy and safety of intravenous neridronic acid in subjects with Complex Regional Pain Syndrome (CRPS).

The trial consisted of an Enrollment Period lasting up to 60 days, Treatment Period A consisting of 4 infusions (neridronic acid 100 mg or placebo) over 10 days, and a Follow-up Period 1 until Week 26. At Week 26, participants meeting the pre-specified criteria entered the open-label Treatment Period B with 4 additional infusions (neridronic acid) over 10 days and follow-up visits until Week 52. Participants not meeting the pre-specified criteria to continue into Treatment Period B continued in Follow-up Period 2 until Week 52.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03560986
Study type Interventional
Source Grünenthal GmbH
Contact
Status Terminated
Phase Phase 3
Start date May 31, 2018
Completion date August 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT01512121 - Spinal Cord Stimulation and Functional MRI
Completed NCT02265848 - High Frequency Stimulation Trials in Patients With Precision Spinal Cord Stimulator System Phase 4
Active, not recruiting NCT01508676 - Effects of Pennsaid on Clinical Neuropathic Pain N/A
Terminated NCT03530345 - Efficacy and Safety of Intravenous Neridronic Acid in CRPS Phase 3
Completed NCT03285113 - A Study to Confirm the Safety of High Frequency DRG Stimulator in Patients With Chronic Lower Limb Pain N/A
Recruiting NCT03686748 - Two Point Discrimination Early Phase 1
Completed NCT01926119 - TMS for CRPS - Pilot Study N/A
Completed NCT02067273 - Transcranial Magnetic Stimulation (TMS) for CRPS N/A
Completed NCT01118988 - Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents N/A
Active, not recruiting NCT02800863 - TARGET Post-Approval Study
Terminated NCT01813149 - Mechanism and Treatment of Sympathetically Maintained Pain N/A